Skip to main content

Table 6 Standards of physiotherapy provision in inpatient care (51 centers) and outpatient care (62 centers)

From: The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey

Inpatient individual

Number of centers providing the type of care

Weeks/year median (IQR)

Sessions/week median (IQR)

Minutes/sessions median (IQR)

Number of centers providing the data to compute the dosage

Dosage in hours/year median (IQR)

 Europe

49

4 (8)

5 (1.2)

45 (30)

38 (78 %)

12.6 (27.5)

 East

6

4 (1)

5.5 (4.8)

52 (15)

6 (100 %)

32 (32.1)

 North

16

4 (24)

4 (1)

45 (20)

11 (69 %)

10 (1.8)

 South

20

4 (16)

5 (0.2)

45 (15)

15 (75 %)

20 (29.4)

 West

7

6 (5)

5 (4.5)

30 (5)

6 (86 %)

24.5 (19.4)

Inpatient group

 Europe

23

4 (7)

5 (5)

45 (16)

19 (83 %)

24 (30.4)

 East

3

4 (1)

6 (3.5)

45 (15)

3 (100 %)

24 (19.5)

 North

9

4 (4)

5 (5.2)

45 (5)

7 (78 %)

18 (16.4)

 South

6

4 (13)

5 (2.2)

52 (60)

5 (83 %)

36 (28.8)

 West

5

8 (21)

10 (9)

40 (15)

4 (80 %)

51.5 (67)

Inpatient autonomous

 Europe

7

4 (22)

5 (1.5)

30 (5)

5 (71 %)

6.0 (1.5)

Outpatient individual

 Europe

58

12 (36)

2 (2)

45 (20)

42 (72 %)

15 (16)

 East

7

8 (14)

2 (2.5)

45 (22)

6 (86 %)

9.8 (5.6)

 North

16

12 (30)

2 (3)

52 (15)

11 (69 %)

9 (14)

 South

25

10 (41)

2 (3)

45 (15)

18 (72 %)

23.2 (21.1)

 West

10

16 (33)

2 (0)

35 (15)

7 (70 %)

13.5 (11)

Outpatient group

 Europe

25

10 (44)

2 (2)

60 (15)

8 (32 %)

40 (30.2)

 East

0

   

0

 

 North

9

10 (11)

2 (1)

60 (15)

2 (22 %)

71 (29)

 South

9

20 (46)

3 (3)

45 (15)

5 (56 %)

30 (25)

 West

7

10 (43)

2 (1.5)

60 (18)

1 (14 %)

150 (0)

Outpatient autonomous

 

 Europe

6

45 (37)

5.5 (1.8)

38 (26)

3 (50 %)

15 (54)

  1. While all 51/62 centers providing inpatient/outpatient care gave details about frequency and timing of care, some misunderstood that the frequency in weeks should reffer to one patient and not to staff workload. Therefore, data from smaller proportion of centers could have been used for dosage computation
  2. Becuse of small number of centers prividing autonomous therapy, data are not broken down by region. Even so, estimates of session frequency have large, especially in outpatient centers, and are not very reliable
  3. Kruskal-Wallis test for the differences in dosage of therapy across regions yielded the following p-values for the inpatient individual, group, autonomous and outpatient individual, group, autonomous therapy respectively: 0.162, 0.538, 0.264, 0.077, 0.070, 0.221. Due to multiple testing the Bonferroni correction should be applied and the value 0.008 is used as threshold instead. The dosage of different types of therapies was not found as different across the regions